Globeimmune Inc
OTC:GBIM
Globeimmune Inc
Depreciation & Amortization
Globeimmune Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Globeimmune Inc
OTC:GBIM
|
Depreciation & Amortization
-$187.3k
|
CAGR 3-Years
41%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Globeimmune Inc's Depreciation & Amortization?
Depreciation & Amortization
-187.3k
USD
Based on the financial report for Dec 31, 2015, Globeimmune Inc's Depreciation & Amortization amounts to -187.3k USD.
What is Globeimmune Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
32%
Over the last year, the Depreciation & Amortization growth was 37%. The average annual Depreciation & Amortization growth rates for Globeimmune Inc have been 41% over the past three years , 32% over the past five years .